EUVIMEDEUVIMED entdecken
Open Access

Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1/2 axis in hepatocellular carcinoma

Ming-Hao Xu, Yi-Min Zheng, Bu-Gang Liang, Wen-Xin Xu, Jun Cao, Pei Wang, Zi-Ying Dong, Chen-Hao Zhou, Hui-Chuan Sun, Ning Ren, Ai-Wu Ke, Ying-Hao Shen

International Journal of Biological Sciences · 2024 · 20 (9) · 3269-3284

DOI: 10.7150/ijbs.96031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Ming-Hao Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Quinolines, Liver Neoplasms, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lenvatinib is the most common multitarget receptor tyrosine kinase inhibitor for the treatment of advanced hepatocellular carcinoma (HCC). Acquired resistance to lenvatinib is one of the major factors leading to the failure of HCC treatment, but the underlying mechanism has not been fully characterized.

Methods

We established lenvatinib-resistant cell lines, cell-derived xenografts (CDXs) and patient-derived xenografts (PDXs) and obtained lenvatinib-resistant HCC tumor tissues for further study.

Results

We found that ubiquitin-specific protease 14 (USP14) was significantly increased in lenvatinib-resistant HCC cells and tumors. Silencing USP14 significantly attenuated lenvatinib resistance in vitro and in vivo. Mechanistically, USP14 directly interacts with and stabilizes calcium- and integrin-binding protein 1 (CIB1) by reversing K48-linked proteolytic ubiquitination at K24, thus facilitating the P21-activated kinase 1 (PAK1)-ERK1/2 signaling axis. Moreover, in vivo adeno-associated virus 9 mediated transduction of CIB1 promoted lenvatinib resistance in PDXs, whereas CIB1 knockdown resensitized the response of PDXs to lenvatinib.

Conclusions

These findings provide new insights into the role of CIB1/PAK1-ERK1/2 signaling in lenvatinib resistance in HCC. Targeting CIB1 and its pathways may be a novel pharmaceutical intervention for the treatment of lenvatinib-resistant HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularQuinolinesLiver NeoplasmsUbiquitin ThiolesterasePhenylurea CompoundsDrug Resistance, Neoplasmp21-Activated KinasesHumansAnimalsMiceCell Line, TumorMAP Kinase Signaling SystemMice, NudeUbiquitination

Stichwörter der Autor:innen

CIB1HCCLenvatinib resistanceUSP14

Substanzen

QuinolinesUbiquitin ThiolesteraselenvatinibPhenylurea Compoundsp21-Activated KinasesUSP14 protein, humanPAK1 protein, human

Autor:innen und Institutionen

  • Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Department of Hepatobiliary Surgery, Clinical Medical College, Yangzhou University, Yangzhou, 225009, China.
  • Department of Digestive Medicine, Wuwei People's Hospital, Gansu, 733000, China.
  • Department of CT/MRI Center, Wuwei People's Hospital, Gansu, 733000, China.
  • Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, 200032, China.

Zitieren

APA

Xu, M. H., Zheng, Y. M., Liang, B. G., Xu, W. X., Cao, J., Wang, P., Dong, Z. Y., Zhou, C. H., Sun, H. C., Ren, N., Ke, A. W., & Shen, Y. H. (2024). Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1/2 axis in hepatocellular carcinoma. International Journal of Biological Sciences, 20(9), 3269-3284. https://doi.org/10.7150/ijbs.96031

Vancouver

Xu MH, Zheng YM, Liang BG, Xu WX, Cao J, Wang P, et al. Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1/2 axis in hepatocellular carcinoma. International Journal of Biological Sciences. 2024;20(9):3269-3284. doi:10.7150/ijbs.96031

BibTeX
@article{Xu2024,
  author = {Xu, Ming-Hao and Zheng, Yi-Min and Liang, Bu-Gang and Xu, Wen-Xin and Cao, Jun and Wang, Pei and Dong, Zi-Ying and Zhou, Chen-Hao and Sun, Hui-Chuan and Ren, Ning and Ke, Ai-Wu and Shen, Ying-Hao},
  title = {Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1/2 axis in hepatocellular carcinoma},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  volume = {20},
  number = {9},
  pages = {3269--3284},
  doi = {10.7150/ijbs.96031}
}
Kostenlos starten →